Primary results of transurethral prostate ethanol injection

Basit Öğe Kaydı
dc.contributor.authorArslan, Mehmet
dc.contributor.authorOzturk, Ahmet
dc.contributor.authorGoger, Yunus Emre
dc.contributor.authorAslan, Erkan
dc.contributor.authorKilinc, Mehmet
dc.date.accessioned2024-02-23T13:59:27Z
dc.date.available2024-02-23T13:59:27Z
dc.date.issued2014
dc.departmentNEÜen_US
dc.description.abstractMinimally invasive methods, especially the novel techniques, gain more and more popularity in benign prostate hyperplasia (BPH) treatment. Transurethral ethanol injection is one of these novel methods as it is easy to apply for BPH treatment and quite successful. The present study evaluates the results of a single-year transurethral ethanol injection prostate (TUEP) follow-up employed for the first time in our country. Fifty-two patients with lower urinary tract symptoms underwent TUEP. It was performed in ten patients under local anesthesia and in 42 patients under sedation. Dehydrated ethanol with a concentration of 95-98 % was injected using transurethral approach with a rigid cystoscope. Forty-two patients were followed for 1 year. At the end of the first year, the average patients' IPSS scores decreased from 22.6 to 12.8 and prostate volume from 49.5 to 38.8 cc. Q-average increased from 3.3 to 7.1 ml/s and Qmax from 6.4 to 9.7 ml/s. Residual urine decreased from 160.1 ml to 68 cc. There were not any dire postoperative complications. In 77.8 % of the patients, TUEP succeeded. In 13.8 % of the patients, alternative treatment methods were to be employed. TUEP, an effective minimally invasive treatment option, can be performed with medically high-risk BPH patients under regional anesthesia. The procedure is easy, inexpensive, safe, and rapid to us. Yet, long-term and multi-centered studies with larger patient series are needed to define further benefits.en_US
dc.identifier.doi10.1007/s11255-014-0693-2
dc.identifier.endpage1713en_US
dc.identifier.issn0301-1623
dc.identifier.issn1573-2584
dc.identifier.issue9en_US
dc.identifier.pmid24705726en_US
dc.identifier.scopus2-s2.0-85027923455en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1709en_US
dc.identifier.urihttps://doi.org/10.1007/s11255-014-0693-2
dc.identifier.urihttps://hdl.handle.net/20.500.12452/11198
dc.identifier.volume46en_US
dc.identifier.wosWOS:000341430800005en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofInternational Urology And Nephrologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBenign Prostate Hyperplasia (Bph)en_US
dc.subjectTransurethral Ethanol Injection Prostate (Tuep)en_US
dc.subjectProstateen_US
dc.subjectMinimally Invasive Methodsen_US
dc.titlePrimary results of transurethral prostate ethanol injectionen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu